Neoadjuvant chemotherapy promotes the expression of HER3 in patients with ovarian cancer-Reference-Cited by-同舟云学术

Neoadjuvant chemotherapy promotes the expression of HER3 in patients with ovarian cancer

Published:2020-10-07 Issue:6 Volume:20 Page:
ISSN:1792-1074
Container-title:Oncology Letters
language:
Short-container-title:Oncol Lett

Author:

Mizuno Takaaki¹^ORCID,Kojima Yuki¹,Yonemori Kan¹,Yoshida Hiroshi²,Sugiura Yukiko³,Ohtake Yohei¹,Okuma Hitomi¹,Nishikawa Tadaaki¹,Tanioka Maki¹,Sudo Kazuki¹,Shimomura Akihiko¹,Noguchi Emi¹,Kato Tomoyasu³,Shimoi Tatsunori¹,Uno Masaya³,Ishikawa Mitsuya³,Fujiwara Yasuhiro¹,Ohe Yuichiro⁴,Tamura Kenji¹

Affiliation:

1. Department of Breast and Medical Oncology, National Cancer Center Hospital, Tokyo 104‑0045, Japan

2. Department of Pathology, National Cancer Center Hospital, Tokyo 104‑0045, Japan

3. Department of Gynecology, National Cancer Center Hospital, Tokyo 104‑0045, Japan

4. The Jikei University Graduate School of Medicine, Tokyo 105‑8461, Japan

Publisher

Spandidos Publications

Subject

Cancer Research,Oncology

Cited by 8 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Expression of Soluble Form of Aurora A as a Predictive Factor for Neoadjuvant Therapy in Breast Cancer Patients: A Single-Center Pilot Study;Cancers;2023-11-16

2. Human Epidermal Growth Factor Receptor 2/Human Epidermal Growth Factor Receptor 3 PET Imaging;PET Clinics;2023-10

3. Changes in HER3 expression profiles between primary and recurrent gynecological cancers;Cancer Cell International;2023-02-03

4. Changes in HER3 expression profiles between primary and recurrent gynecological cancers;2022-12-12

5. The Role of Circulating Tumor Cells in Ovarian Cancer Dissemination;Cancers;2022-12-07